PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Alzheimer's patients' cognition improves with Sargramostim (GM-CSF), new study shows

Clinical trial participants saw memory-enhancing benefits and disease modifying activities when taking Sargramostim

2021-03-24
(Press-News.org) A new study suggests that Sargramostim, a medication often used to boost white blood cells after cancer treatments, is also effective in treating and improving memory in people with mild-to-moderate Alzheimer's disease. This medication comprises of a natural human protein produced by recombinant DNA technology (yeast-derived rhu GM-CSF/Leukine®).

The study, from the University of Colorado Alzheimer's and Cognition Center at the University of Colorado Anschutz Medical Campus (CU Anschutz), presents evidence from their clinical trial that shows that Sargramostim may have both disease-modifying and cognition-enhancing activities in Alzheimer's disease patients. It was published online today by Alzheimer's & Dementia: Translational Research and Clinical Interventions, an open access journal of the Alzheimer's Association.

"The goal of the clinical trial was to examine the impact of a natural human protein called granulocyte-macrophage colony stimulating factor (GM-CSF) on people living with Alzheimer's disease. We tested GM-CSF because people with rheumatoid arthritis tend not to get Alzheimer's disease and we had previously found this protein, which is increased in the blood of people with rheumatoid arthritis, reduced amyloid deposition in Alzheimer's mice and returned their poor memory to normal after a few weeks of treatment. Thus, naturally increased levels of GM-CSF in people with rheumatoid arthritis may be one reason that they are protected from Alzheimer's disease," said Huntington Potter, PhD, director of the CU Alzheimer's and Cognition Center, who together with Jonathan Woodcock, Timothy Boyd and collaborators carried out the new trial.

"Human GM-CSF is the active compound in the known human drug Sargramostim, and we are the first to study its effect on people with Alzheimer's disease."

GM-CSF/Sargramostim is used to stimulate the bone marrow to make more white blood cells of a particular kind called macrophages and granulocytes, as well as progenitor cells that repair blood vessels. These white blood cells circulate throughout the body and remove cells, bacteria and amyloid deposits that aren't supposed to be there, as well as promoting repair to damaged blood vessels and to the brain.

The researchers carried out a randomized, double-blind, placebo-controlled phase II trial to test the safety and efficacy of Sargramostim treatment in participants with mild-moderate Alzheimer's disease. Study participants who met eligibility criteria were randomized to receive injections of either Sargramostim (20 participants took a standard FDA dosage 250 mcg/m2/day subcutaneous injection for five days a week for three weeks) or placebo (20 participants took saline for five days a week for three weeks). The majority of the participants from the study were recruited and treated at CU Anschutz with a few from the University of South Florida.

The CU Anschutz researchers then conducted and studied multiple neurological, neuropsychological, cell, cytokine, Alzheimer's pathology biomarkers and neuroimaging assessments.

They found that short-term Sargramostim treatment increased innate and other immune cells, modulated cytokine measures, and was safe and well-tolerated by participants. They also found cognition memory improved by almost two points in the 30 point Mini-Mental State Exam. Measures of blood biomarkers of Alzheimer's disease--brain amyloid, tangles, and neurodegeneration--all improved toward normal.

"These results suggest that short-term Sargramostim treatment leads to innate immune system activation, cognition and memory improvement, and partial normalization of blood measures of amyloid and tau pathology and neuronal damage in participants with mild-to-moderate Alzheimer's disease," said Potter.

"This surprising finding that stimulating the innate immune system and modulating inflammation may be a new treatment approach and induced us to start a larger trial of Sargramostim in Alzheimer's disease with more participants treated over a longer time."

INFORMATION:

This new trial will be funded by the Alzheimer's Association/Part The Cloud, the University of Colorado, the Global Down Syndrome Foundation and by a large grant recently awarded from the National Institute on Aging.

About the University of Colorado Anschutz Medical Campus The University of Colorado Anschutz Medical Campus is a world-class medical destination at the forefront of transformative science, medicine, education, and patient care. The campus encompasses the University of Colorado health professional schools, more than 60 centers and institutes, and two nationally ranked independent hospitals that treat more than two million adult and pediatric patients each year. Innovative, interconnected and highly collaborative, together we deliver life-changing treatments, patient care, professional training, and conduct world-renowned research. For more information, visit http://www.cuanschutz.edu.



ELSE PRESS RELEASES FROM THIS DATE:

Midlife loneliness is a risk factor for Dementia and Alzheimer's disease

2021-03-24
(Boston)--Being persistently lonely during midlife (ages 45-64) appears to make people more likely to develop dementia and Alzheimer's Disease (AD) later in life. However, people who recover from loneliness, appear to be less likely to suffer from dementia, compared to people who have never felt lonely. Loneliness is a subjective feeling resulting from a perceived discrepancy between desired and actual social relationships. Although loneliness does not itself have the status of a clinical disease, it is associated with a range of negative health outcomes, including sleep disturbances, depressive symptoms, cognitive impairment, and stroke. Still, feeling lonely may happen to anyone at some point in life, ...

1º of global warming causes a ~50% increase in population displacement risk

2021-03-24
A new study shows that if the population were fixed at current levels, the risk of population displacement due to river floods would rise by ~50% for each degree of global warming. However, if population increases are taken into account, the relative global flood displacement risk is significantly higher. The research, by an international team from Switzerland, Germany, and the Netherlands, used a global climate-, hydrology- and inundation-modelling chain, including multiple alternative climate and hydrological models, to quantify the effect of global warming on displacement ...

Once-in-a-century UK wildfire threats could happen most years by end of century

2021-03-24
Extremely hot and dry conditions that currently put parts of the UK in the most severe danger of wildfires once a century could happen every other year in a few decades' time due to climate change, new research has revealed. A study, led by the University of Reading, predicting how the danger of wildfires will increase in future showed that parts of eastern and southern England may be at the very highest danger level on nearly four days per year on average by 2080 with high emissions, compared to once every 50-100 years currently. Wildfires need a source of ignition which ...

Deforestation, forest conversion and palm oil plantations linked to disease outbreaks

2021-03-24
Deforestation, certain types of reforestation and commercial palm plantations correlate with increasing outbreaks of infectious disease, shows a new study in Frontiers in Veterinary Science. This study offers a first global look at how changes in forest cover potentially contribute to vector-borne diseases--such as those carried by mosquitos and ticks--as well as zoonotic diseases, like Covid-19, which jumped from an animal species into humans. The expansion of palm oil plantations in particular corresponded to significant rises in vector-borne ...

Meta-analysis shows children prefer people who speak like them

2021-03-24
Research shows that children prefer to befriend, listen to, and imitate people who speak similarly to them. While most of this research has been conducted on monolingual (speaking only one language) children from Western societies, a growing subset of research has begun examining whether this pattern holds for children from more diverse linguistic and cultural backgrounds. A new meta-analysis including studies with monolingual as well as bilingual children helps to shed light on the range of factors that contribute to the development of linguistic-based biases in early childhood. Understanding these patterns can eventually guide efforts to diminish biases based on how one speaks. The findings were published in a Child Development article written by researchers ...

Overhearing negative claims about social groups may influence development of bias in children

2021-03-24
Throughout the world, societies discriminate against and mistreat members of certain social groups. Young children may express intergroup biases that lead to such outcomes, demonstrating preferences for their own over other groups. How these biases develop is an important topic of study in today's climate. A new longitudinal study mimicked a situation in which children might overhear derogatory messages about a new social group. The study revealed that overhearing a stranger's negative claims about a social group, even in a brief comment, can have a lasting influence on children's attitudes towards the group. The findings were published in a Child ...

Gender bias in the workplace starts with communication during recruitment

Gender bias in the workplace starts with communication during recruitment
2021-03-24
80% of jobs are communicated to people informally and these communications are often riddled with gender bias, providing a female (versus male) candidate with a less positive description of a leadership position, especially when the decision maker is more conservative. These are the findings of a new study by Ekaterina Netchaeva, of Bocconi University's Department of Management and Technology, looking at the role gender bias may play in the leadership gap between men and women. The persistence of a gender wage gap indicates that while discrimination is ending, bias lingers. The World Economic Forum's Global Gender Gap Report 2020 found "there is still a 31.4% average gender gap that remains to be closed globally." With this ...

How blockchain and machine learning can deliver the promise of omnichannel marketing

2021-03-24
Researchers from University of Minnesota, New York University, University of Pennsylvania, BI Norwegian Business School, University of Michigan, National Bureau of Economic Research, and University of North Carolina published a new paper in the Journal of Marketing that examines how advances in machine learning (ML) and blockchain can address inherent frictions in omnichannel marketing and raises many questions for practice and research. The study, forthcoming in the Journal of Marketing, is titled "Informational Challenges in Omnichannel Marketing Remedies and ...

Extreme temperatures, heat stress and forced migration

2021-03-24
The study, building on cooperation between climate scientists from the MENA region, aimed at assessing emerging heatwave characteristics. The research team used a first-of-its-kind multi-model ensemble of climate projections designed exclusively for the geographic area. Such detailed downscaling studies had been lacking for this region. The researchers then projected future hot spells and characterised them with the Heat Wave Magnitude Index. The good match among the model results and with observations indicates a high level of confidence in the heat wave projections. "Our results for a business-as-usual ...

Recharge your batteries

Recharge your batteries
2021-03-24
March 24, 2021 -- Perhaps the most frustrating limitation of owning an all-electric car is how long it takes to fully charge the battery. For a Tesla, for example, it takes about 40 minutes to charge it to 80% capacity using the most powerful charging station. Scientists have long thought the laws of physics limited how fast you could safely recharge a battery, but new research by University of Utah chemical engineering assistant professor Tao Gao has opened the door to creating a battery that can be recharged in just a fraction of the time. Gao's research was detailed in a new paper published in the scientific journal Joule. The study was conducted while Gao was a postdoctoral researcher at the Massachusetts Institute of Technology under ...

LAST 30 PRESS RELEASES:

Are lifetimes of big appliances really shrinking?

Pink skies

Monkeys are world’s best yodellers - new research

Key differences between visual- and memory-led Alzheimer’s discovered

% weight loss targets in obesity management – is this the wrong objective?

An app can change how you see yourself at work

NYC speed cameras take six months to change driver behavior, effects vary by neighborhood, new study reveals

New research shows that propaganda is on the rise in China

Even the richest Americans face shorter lifespans than their European counterparts, study finds

Novel genes linked to rare childhood diarrhea

New computer model reveals how Bronze Age Scandinavians could have crossed the sea

Novel point-of-care technology delivers accurate HIV results in minutes

Researchers reveal key brain differences to explain why Ritalin helps improve focus in some more than others

Study finds nearly five-fold increase in hospitalizations for common cause of stroke

Study reveals how alcohol abuse damages cognition

Medicinal cannabis is linked to long-term benefits in health-related quality of life

Microplastics detected in cat placentas and fetuses during early pregnancy

Ancient amphibians as big as alligators died in mass mortality event in Triassic Wyoming

Scientists uncover the first clear evidence of air sacs in the fossilized bones of alvarezsaurian dinosaurs: the "hollow bones" which help modern day birds to fly

Alcohol makes male flies sexy

TB patients globally often incur "catastrophic costs" of up to $11,329 USD, despite many countries offering free treatment, with predominant drivers of cost being hospitalization and loss of income

Study links teen girls’ screen time to sleep disruptions and depression

Scientists unveil starfish-inspired wearable tech for heart monitoring

Footprints reveal prehistoric Scottish lagoons were stomping grounds for giant Jurassic dinosaurs

AI effectively predicts dementia risk in American Indian/Alaska Native elders

First guideline on newborn screening for cystic fibrosis calls for changes in practice to improve outcomes

Existing international law can help secure peace and security in outer space, study shows

Pinning down the process of West Nile virus transmission

UTA-backed research tackles health challenges across ages

In pancreatic cancer, a race against time

[Press-News.org] Alzheimer's patients' cognition improves with Sargramostim (GM-CSF), new study shows
Clinical trial participants saw memory-enhancing benefits and disease modifying activities when taking Sargramostim